Rindy Dhillon

Rindy Dhillon is a seasoned pharmaceutical executive with extensive experience in marketing and leadership roles across various therapeutic areas. Currently serving as Vice President of US Oncology Lung and GI Marketing at Bristol Myers Squibb since March 2022, Rindy has previously held senior positions at Eidos Therapeutics, Novartis, Amgen, and Gilead Sciences. Notable roles include Senior Vice President at Eidos Therapeutics, Vice President of US Cardiovascular, Renal, and Metabolism Franchise at Novartis, and Director of US Rheumatology Marketing at Amgen. Rindy's career at Novartis also encompassed diverse roles in hematology and oncology marketing. Rindy holds a Doctor of Pharmacy (Pharm.D.) from Rutgers University and the University of the Sciences.